Palonosetron has been found to be effective in treating chemotherapy-induced nausea and vomiting, but no other studies that have compared it with the other 5-HT3 RAs are currently available.
Claudio Faria, PharmD, MPH
Advertisement
Articles by Claudio Faria, PharmD, MPH
Dose consolidation and quantity limit initiatives decreased utilization and cost outcomes for select mental health drugs in a fee-for-service Medicaid environment.
Advertisement
Latest Updated Articles
- Cost and Utilization Outcomes Associated With a Dosage Consolidation and Quantity Limits Program
Published: October 27th 2010 | Updated:
- 5-HT3 Receptor Antagonist Effects in Cancer Patients With Multiple Risk Factors
Published: May 15th 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Addressing Drug Resistance in Lung Cancer
2
From Mutation to Medicine: Targeted Therapies in Lung Cancer
3
Final EMBARK Data Show “Almost Unprecedented” Reduction in Risk of Death With Enzalutamide Plus ADT in Biochemically Recurrent Prostate Cancer
4
Five-Year NATALEE Data Show Ribociclib Improves Outcomes in High-Risk HR+/HER2– Early Breast Cancer
5
